Liver Diseases  >>  SCY-635  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SCY-635 / SCYNEXIS
NCT01290965: Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

Completed
1
57
US
Placebo, SCY-635
Scynexis, Inc.
Chronic Hepatitis C
12/08
01/09

Download Options